SCHEMBL5505753

SCHEMBL5505753

CCCCCC(CC)CS

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
LMNA P02545 1/20 0.48
CYP3A4 P08684 4/20 0.46
TSHR P16473 3/20 0.46
OPRM1 P35372 1/20 0.40
CA2 P00918 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GSTK1 Q9Y2Q3 2/20 0.37
DNM1 Q05193 2/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
ATM Q13315 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10998500 0.97 LMNA (0.52) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL9819401 0.97 LMNA (0.52) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL10868798 0.97 LMNA (0.52) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL28101187 0.97 LMNA (0.52) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL7755390 0.97 LMNA (0.52) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL1110143 0.95 ALDH1A1 (0.44) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL186018 0.92
SCHEMBL10699211 0.90 ALDH1A1 (0.54) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL9744478 0.90 ALDH1A1 (0.54) ALDH1A1TDP1LMNACYP3A4TSHR
SCHEMBL26617320 0.89 LMNA (0.52) ALDH1A1TDP1LMNACYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105985774-A Nanocrystalline-ligand compound, preparation method of nanocrystalline-ligand compound, printing material and use of printing material 纳晶科技股份有限公司 2016-10-05 CN claimed
WO-2023210569-A1 NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM, AND ORGANIC SEMICONDUCTOR ELEMENT 東ソー株式会社 2023-11-02 WO disclosed
US-20230058125-A1 NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE HOLMES STEPHEN F (US) 2023-02-23 US disclosed
US-20230058125-A1 NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE HOLMES STEPHEN F (US) 2023-02-23 US disclosed
US-20200116684-A1 NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE HOLMES STEPHEN F (US) 2020-04-16 US disclosed
CN-105985774-B The application of nanocrystalline-ligand complex, preparation method, printing material and printing material 纳晶科技股份有限公司 2019-05-28 CN disclosed
US-10131646-B2 Aromatic sulfonium salt compound, photoacid generator, resist composition, cationic polymerization initiator, and cationically polymerizable composition ADEKA CORPORATION (JP) 2018-11-20 US disclosed
US-20180079738-A1 AROMATIC SULFONIUM SALT COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION ADEKA CORPORATION (JP) 2018-03-22 US disclosed
EP-3272744-A1 AROMATIC SULFONIUM SALT COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION Adeka Corporation (JP) 2018-01-24 EP disclosed
CN-105985774-A Nanocrystalline-ligand compound, preparation method of nanocrystalline-ligand compound, printing material and use of printing material 纳晶科技股份有限公司 2016-10-05 CN disclosed
US-20150033825-A1 NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE HOLMES STEPHEN F (US) 2015-02-05 US disclosed
US-20150033825-A1 NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE HOLMES STEPHEN F (US) 2015-02-05 US disclosed
US-7157442-B2 Antibacterial compound SANKYO COMPANY, LIMITED (JP) 2007-01-02 US disclosed
EP-1209166-B1 NOVEL A-500359 DERIVATIVES SANKYO CO (JP) 2004-03-31 EP disclosed
US-20030171330-A1 Antibacterial compound SANKYO COMPANY, LIMITED (JP) 2003-09-11 US disclosed
EP-1209166-A1 NOVEL A-500359 DERIVATIVES Sankyo Company, Limited (JP) 2002-05-29 EP disclosed
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed
US-4511753-A Selective removal of vinylidene olefin from olefin mixtures ETHYL CORPORATION (US) 1985-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10131646-B2 Aromatic sulfonium salt compound, photoacid generator, resist composition, cationic polymerization initiator, and cationically polymerizable composition ASIC1, NOX5, SLC6A19 ALDH1A1 2818/4885TDP1 3936/4885LMNA 4016/4885
US-20030171330-A1 Antibacterial compound TLR1, MPO, O60361 ALDH1A1 356/4885TDP1 4351/4885LMNA 4477/4885
US-20180079738-A1 AROMATIC SULFONIUM SALT COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION ASIC1, NOX5, SLC6A19 ALDH1A1 2818/4885TDP1 3936/4885LMNA 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.